Cancer Stem Cell Assay Directed Chemotherapy in Recurrent Platinum Resistant Ovarian Cancer (NCT03949283)
Standard Chemotherapy Versus Cancer Stem Cell Assay Directed Chemotherapy in Recurrent Platinum Resistant Ovarian Cancer
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this clinical study is to confirm the utility of chemosensitivity (ChemoID) tumor testing on cancer stem cells as a predictor of clinical response in recurrent platinum resistant epithelial ovarian cancer (EOC), fallopian tube, or primary peritoneal cancer. Population studied will be female participants experiencing a recurrent platinum-resistant ovarian cancer (no mucinous, low grade serous, or pure sarcoma types), with ≤ 5 prior treatments, and a performance status 0-1.
Who can join: Review the eligibility criteria below.
Location: Kaiser Permanente — Los Angeles, California
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (8 Sites)
- Kaiser Permanente — Los Angeles, California
- Miami Cancer Institute/Baptist Health South Florida — Miami, Florida
- LSU Health Sciences Center — New Orleans, Louisiana
- University of Cincinnati Cancer Institute — Cincinnati, Ohio
- University of Oklahoma Health Sciences Center — Oklahoma City, Oklahoma
- West Penn Hospital, Allegheny Health Network — Pittsburgh, Pennsylvania
- Charleston Area Medical Center (CAMC) — Charleston, West Virginia
- Edwards Comprehensive Cancer Center - Cabell Huntington Hospital — Huntington, West Virginia
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
Explore by condition: All Recurrent Ovarian Carcinoma clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.